CN105902607A - Fiveleaf gynostemma herb-containing traditional Chinese medicine composition - Google Patents
Fiveleaf gynostemma herb-containing traditional Chinese medicine composition Download PDFInfo
- Publication number
- CN105902607A CN105902607A CN201610487404.7A CN201610487404A CN105902607A CN 105902607 A CN105902607 A CN 105902607A CN 201610487404 A CN201610487404 A CN 201610487404A CN 105902607 A CN105902607 A CN 105902607A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- medicine composition
- radix
- raw material
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
- A61K36/424—Gynostemma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/254—Acanthopanax or Eleutherococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/487—Psoralea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a fiveleaf gynostemma herb-containing traditional Chinese medicine composition with a function of controlling radiation. The traditional Chinese medicine composition can effectively solve the problem of low immunity caused by receiving radiation for a long time, so as to reduce the harm of the radiation. The traditional Chinese medicine composition is prepared from the following raw materials: 20-30 parts of fiveleaf gynostemma herb, 10-20 parts of acanthopanax root, 10-15 parts of radix astragali, 8-10 parts of fructus psoraleae, 5-10 parts of rhizoma chuanxiong, 3-5 parts of ginseng and 1-5 parts of folium ginkgo. The traditional Chinese medicine composition is prepared by chopping the medicine raw materials and then mixing together, decocting the medicine mixture by using 70-85% alcohol, filtering the decocted fluid, and then carrying out vacuum concentration to obtain thick paste, namely the traditional Chinese medicine composition.
Description
Technical field
The present invention relates to compositions, a kind of Chinese medicine composition preventing and treating radiation.
Background technology
Along with development and the extensive application of radiotherapy clinically of nuclear technology, particularly at medical domain, radiodiagnosis
Non-with treatment use extensively, clinically, tumor patient is carried out radiotherapy and has become as the conventional means of oncotherapy, how to prevent
Only radiation damage is increasingly subject to the attention of people.People start to try to explore effectively to radiate protective agents.
Patent CN 201410022608.4 discloses a kind of with Radix Pseudostellariae, Fructus Psoraleae, Fructus Lycii, Herba Dendrobii etc. as component
Compositions has good radiation resistance, and patent CN201510455861.3 discloses a kind of nutrition group reducing radiation hazradial bundle
Compound, has certain radiation resistance.
Inventor, through the excavation to Chinese medicine, through great many of experiments, has filtered out the compositions of the application, and it is anti-
Radiation aspect has good application.
Summary of the invention
For above-mentioned situation, the present invention provides a kind of Chinese medicine composition preventing and treating radiation, by the collaborative work of different Chinese medicines
With, improve immunity, for alleviating or reduce the long-term harm accepting radiation.
The present invention adopts the following technical scheme that, this Chinese medicine composition, makes with following component for raw material: Herb Gynostemmae Pentaphylli, thorn five
Add, the Radix Astragali, Fructus Psoraleae, Rhizoma Chuanxiong, Radix Ginseng, Folium Ginkgo, by above-mentioned raw medicinal material raw material chopping, mix, use ethanol water
Solution decocts, and decoction liquor filters, and concentrating under reduced pressure obtains the mastic of thickness, obtains described Chinese medicine composition.
Further, preferably, the Chinese medicine composition that the present invention provides, make with following component for raw material: strand
Stock blue 20-30 part, Radix Et Caulis Acanthopanacis Senticosi 10-20 part, Radix Astragali 10-15 part, Fructus Psoraleae 8-10 part, Rhizoma Chuanxiong 5-10 part, Radix Ginseng 3-5 part, Semen Ginkgo
Leaf 1-5 part.By above-mentioned medicinal raw material chopping, mixing, decoct with the ethanol of 70-85%, decoction liquor filters, and reduces pressure dense
Contracting, obtains the mastic of thickness, obtains described Chinese medicine composition.
Further preferably with Herb Gynostemmae Pentaphylli 25-30 part, Radix Et Caulis Acanthopanacis Senticosi 12-20 part, Radix Astragali 10-12 part, Fructus Psoraleae 8-10 part, Rhizoma Chuanxiong
5-10 part, Radix Ginseng 3-5 part, Folium Ginkgo 2-5 part are as raw material；
It is highly preferred that with Herb Gynostemmae Pentaphylli 25-30 part, Radix Et Caulis Acanthopanacis Senticosi 12-16 part, Radix Astragali 10-12 part, Fructus Psoraleae 8-10 part, Rhizoma Chuanxiong 5-8
Part, Radix Ginseng 3 parts, Folium Ginkgo 2-5 part are as raw material；Most preferably with Herb Gynostemmae Pentaphylli 28 parts, Radix Et Caulis Acanthopanacis Senticosi 14 parts, the Radix Astragali 10 parts, Fructus Psoraleae 8
Part, Rhizoma Chuanxiong 8 parts, Radix Ginseng 3 parts, Folium Ginkgo 3 parts are as raw material.
Further, ethanol water volumetric usage is 6-10 times of raw medicinal material weight, preferred alcohol aqueous solution volume
Consumption is 8 times of raw medicinal material weight.
Detailed description of the invention
For the object, technical solutions and advantages of the present invention are better described, below in conjunction with specific embodiment to the present invention
It is described further.
Embodiment 1
Herb Gynostemmae Pentaphylli 20 parts, Radix Et Caulis Acanthopanacis Senticosi 15 parts, the Radix Astragali 12 parts, Fructus Psoraleae 8 parts, Rhizoma Chuanxiong 10 parts, Radix Ginseng 5 parts, Folium Ginkgo 4 parts；By upper
The raw medicinal material chopping stated, mixes, and the ethanol with 75% decocts, and decoction liquor filters, and concentrating under reduced pressure obtains the cream of thickness
Body, wherein ethanol volumetric usage is medicinal raw material weight 6 times of 75%.
Embodiment 2
Herb Gynostemmae Pentaphylli 28 parts, Radix Et Caulis Acanthopanacis Senticosi 14 parts, the Radix Astragali 10 parts, Fructus Psoraleae 8 parts, Rhizoma Chuanxiong 8 parts, Radix Ginseng 3 parts, Folium Ginkgo 3 parts；By above-mentioned
Raw medicinal material chopping, mix, with 80% ethanol decoct, decoction liquor filtration, concentrating under reduced pressure, obtain the mastic of thickness,
Wherein ethanol volumetric usage is medicinal raw material weight 8 times of 80%.
Embodiment 3
Herb Gynostemmae Pentaphylli 25 parts, Radix Et Caulis Acanthopanacis Senticosi 20 parts, the Radix Astragali 11 parts, Fructus Psoraleae 10 parts, Rhizoma Chuanxiong 5 parts, Radix Ginseng 3 parts, Folium Ginkgo 1 part.By upper
The medicinal raw material chopping stated, mixes, and the ethanol with 85% decocts, and decoction liquor filters, and concentrating under reduced pressure obtains the cream of thickness
Body, wherein ethanol volumetric usage is medicinal raw material weight 10 times of 85%.
Embodiment 4
Herb Gynostemmae Pentaphylli 30 parts, Radix Et Caulis Acanthopanacis Senticosi 16 parts, the Radix Astragali 13 parts, Fructus Psoraleae 10 parts, Rhizoma Chuanxiong 5 parts, Radix Ginseng 3 parts, Folium Ginkgo 5 parts.By upper
The medicinal raw material chopping stated, mixes, and the ethanol with 70% decocts, and decoction liquor filters, and concentrating under reduced pressure obtains the cream of thickness
Body, obtains described Chinese medicine composition, wherein ethanol volumetric usage is medicinal raw material weight 9 times of 70%.
1, Antiradiation injury experiment:
With mice as object of study, investigate the Chinese medicine composition of the embodiment of the present invention 2 to 30 days survival rates of raying mice
Affecting, the human body of the Chinese medicine composition of the present invention recommends consumption to be 5g/60kg.BW every day, and following basic, normal, high dosage group is suitable
In 1 times, 5 times, 10 times of human body recommended dose, and test as follows:
(1) selecting SD mice, female 75, weight range is 20-22g.Raise one week in the case of feeding environment is identical；
(2) being randomly divided into 5 groups, often group 15, is divided into normal group, model control group, low dose group, middle dosage group, high dose group；
Normal group refuses any process, and model group gives distilled water, and basic, normal, high dosage component does not give the embodiment 2 of corresponding dosage
Chinese medicine composition, uses the mode of gavage (ig), every day 1 time, continuous gavage 30d；
5h after (3) the 30th days gavages, in addition to normal group, remaining 4 groups all carry out whole body disposable 60Co gamma-rays irradiate, irradiate away from
From for 1.0m, exposure dose is 8.5Gy；After irradiation, observed and recorded respectively organizes the survival state of mice, body weight change, calculates each group little
The mean survival time of Mus, 30d survival rate etc..
The Chinese medicine composition of the present invention is as shown in table 1 to the result (x ± s) of 30 days survival rates of raying mice.
Table 1
As it can be seen from table 1 when give the Chinese medicine composition of the present invention with low middle high dose, it is the poorest that it has with matched group
Different, it is seen then that the Chinese medicine composition of the present invention can significantly improve the survival rate by 8.5Gy roentgenization mice 30d, extend by spoke
Penetrate the life span of mice.Therefore, the Chinese medicine composition of the present invention has the effect of pre-radioprotective.
2, the impact on spleen
Spleen is maximum lymphatic organ, is also one of important peripheral immune organ, containing substantial amounts of T cell, NKT
Cell and Tumor-infiltrating lymphocytes etc..Spleen is also the place that haematogenous antigen produces immunne response, can synthesize
And secrete such as the bioactive substance such as complement, IFN, spleen weight reflects the immune state of body indirectly.Research display, irradiates comparison
Group mice spleen heavily significantly reduces, and gives the present invention Chinese medicine composition of high, medium and low dosage, significantly increases mice after irradiation
Spleen weight, the present invention is high, middle, and dosage group compares with irradiation control group, has significant difference.Result is as shown in table 2:
The impact on spleen of table 2 Chinese medicine composition of the present invention
Above experimental result shows indirectly, and the Chinese medicine composition of the present invention can improve body immunity, thus prevents and treats radiation, fall
Low emissivity endangers.
The foregoing is only the optimal case study on implementation of the present invention, be merely illustrative for the purpose of the present invention, and unrestricted
Property.Those skilled in the art understands, it can be carried out some and revise in the scope of the claims in the present invention, but all
To fall within the scope of protection of the present invention.
Claims (6)
1. the Chinese medicine composition of the preventing and treating radiation containing Herb Gynostemmae Pentaphylli, it is characterised in that described Chinese medicine composition uses such as lower section
Prepared by method: with Herb Gynostemmae Pentaphylli, Radix Et Caulis Acanthopanacis Senticosi, the Radix Astragali, Fructus Psoraleae, Rhizoma Chuanxiong, Radix Ginseng, Folium Ginkgo as raw material, is shredded by raw material, is blended in one
Rising, decoct with ethanol water, decoction liquor filters, and concentrating under reduced pressure obtains the mastic of thickness, obtains described Chinese medicine composition.
Chinese medicine composition the most according to claim 1, it is characterised in that the consumption of each raw material is: Herb Gynostemmae Pentaphylli 20-30 part, thorn
Slender acanthopanax 10-20 part, Radix Astragali 10-15 part, Fructus Psoraleae 8-10 part, Rhizoma Chuanxiong 5-10 part, Radix Ginseng 3-5 part, Folium Ginkgo 1-5 part.
3. according to the Chinese medicine composition described in claim 1-2, it is characterised in that the consumption of each raw material is: Herb Gynostemmae Pentaphylli 25-30 part,
Radix Et Caulis Acanthopanacis Senticosi 12-20 part, Radix Astragali 10-12 part, Fructus Psoraleae 8-10 part, Rhizoma Chuanxiong 5-10 part, Radix Ginseng 3-5 part, Folium Ginkgo 2-5 part.
4. according to the Chinese medicine composition described in claim 1-3, it is characterised in that the consumption of each raw material is: Herb Gynostemmae Pentaphylli 28 parts, thorn
Slender acanthopanax 14 parts, the Radix Astragali 10 parts, Fructus Psoraleae 8 parts, Rhizoma Chuanxiong 8 parts, Radix Ginseng 3 parts, Folium Ginkgo 3 parts.
5. according to the Chinese medicine composition described in claim 1-4, it is characterised in that described ethanol water is the ethanol of 70-85%,
Ethanol water volumetric usage is 6-10 times of raw medicinal material weight.
6. according to the Chinese medicine composition described in claim 1-5, it is characterised in that ethanol water volumetric usage is raw material weight
8 times.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610487404.7A CN105902607A (en) | 2016-06-29 | 2016-06-29 | Fiveleaf gynostemma herb-containing traditional Chinese medicine composition |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610487404.7A CN105902607A (en) | 2016-06-29 | 2016-06-29 | Fiveleaf gynostemma herb-containing traditional Chinese medicine composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105902607A true CN105902607A (en) | 2016-08-31 |
Family
ID=56758943
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610487404.7A Pending CN105902607A (en) | 2016-06-29 | 2016-06-29 | Fiveleaf gynostemma herb-containing traditional Chinese medicine composition |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105902607A (en) |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1413613A (en) * | 2002-02-19 | 2003-04-30 | 中国人民解放军总装备部航天医学工程研究所 | Medicine for anti-microwave, radiation and reducing toxic and side effect of radiotherapy and chemotherapy and its preparation method |
| CN1729816A (en) * | 2005-07-30 | 2006-02-08 | 吴煌发 | Radiation resistant tea |
| CN101361811A (en) * | 2008-09-16 | 2009-02-11 | 东莞市赫尔逊生物科技有限公司 | Radiation resistant traditional Chinese medicine combination and preparation method thereof |
| CN102380016A (en) * | 2011-11-22 | 2012-03-21 | 中国人民解放军第三军医大学第二附属医院 | Anti-radiation traditional Chinese medicine composition |
| CN102389511A (en) * | 2011-11-22 | 2012-03-28 | 中国人民解放军第三军医大学第二附属医院 | Anti-radiation Chinese medicine preparation and preparation method thereof |
| CN104825824A (en) * | 2015-05-25 | 2015-08-12 | 济南新斯诺生物技术有限公司 | Anti-radiation traditional Chinese medicine gel for external application and method for manufacturing anti-radiation traditional Chinese medicine gel |
| CN105194083A (en) * | 2015-09-22 | 2015-12-30 | 长春中医药大学 | Medicine composition for enhancing immunity and resisting radiation and preparation method thereof |
-
2016
- 2016-06-29 CN CN201610487404.7A patent/CN105902607A/en active Pending
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1413613A (en) * | 2002-02-19 | 2003-04-30 | 中国人民解放军总装备部航天医学工程研究所 | Medicine for anti-microwave, radiation and reducing toxic and side effect of radiotherapy and chemotherapy and its preparation method |
| CN1729816A (en) * | 2005-07-30 | 2006-02-08 | 吴煌发 | Radiation resistant tea |
| CN101361811A (en) * | 2008-09-16 | 2009-02-11 | 东莞市赫尔逊生物科技有限公司 | Radiation resistant traditional Chinese medicine combination and preparation method thereof |
| CN102380016A (en) * | 2011-11-22 | 2012-03-21 | 中国人民解放军第三军医大学第二附属医院 | Anti-radiation traditional Chinese medicine composition |
| CN102389511A (en) * | 2011-11-22 | 2012-03-28 | 中国人民解放军第三军医大学第二附属医院 | Anti-radiation Chinese medicine preparation and preparation method thereof |
| CN104825824A (en) * | 2015-05-25 | 2015-08-12 | 济南新斯诺生物技术有限公司 | Anti-radiation traditional Chinese medicine gel for external application and method for manufacturing anti-radiation traditional Chinese medicine gel |
| CN105194083A (en) * | 2015-09-22 | 2015-12-30 | 长春中医药大学 | Medicine composition for enhancing immunity and resisting radiation and preparation method thereof |
Non-Patent Citations (2)
| Title |
|---|
| 林余霖: "《图解本草纲目》", 28 February 2015, 军事医学科学出版社 * |
| 苗明三主编: "《中药药理学》", 31 March 2013, 湖南科学技术出版社 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102018937B (en) | Medicament for treating acne and preparation method thereof | |
| CN107007696B (en) | Traditional Chinese medicine compound enema preparation for treating severe acute pancreatitis or incomplete intestinal obstruction | |
| CN102370686B (en) | Medicinal composition for treating chronic liver disease and application thereof | |
| CN102940799A (en) | Traditional Chinese medicine composition for treating leucoderma and preparation method thereof | |
| CN102935133B (en) | Traditional Chinese medicine composition for treating rheumatic arthritis as well as preparation method and application thereof | |
| CN101632817A (en) | Chinese medicinal composition for treating breast lumps | |
| CN105902607A (en) | Fiveleaf gynostemma herb-containing traditional Chinese medicine composition | |
| CN110742980B (en) | Traditional Chinese medicine composition for treating irritable bowel syndrome and preparation method and application thereof | |
| CN103768414A (en) | Traditional Chinese medicinal formula for treating pertussis | |
| CN102266434B (en) | Chinese medicinal composition for resisting tumor metastasis and preparation method thereof | |
| CN101745080A (en) | Chinese patent medicine for treating leukemia | |
| CN104127602A (en) | Traditional Chinese medicine for treating fatty liver | |
| CN101167994A (en) | Traditional Chinese medicinal composition for treating infantile chronic nephritis | |
| CN102525872A (en) | Hair renewal fluid and manufacture method thereof | |
| CN105902970A (en) | Chuanxiong rhizome-containing traditional Chinese medicine composition for preventing and treating radiation | |
| CN103860869A (en) | Traditional Chinese medicine for treating gestational hypertension | |
| CN103768485A (en) | Traditional Chinese medicine prescription capable of treating vomit | |
| CN103768259A (en) | Traditional Chinese medicinal prescription for treating acute bronchitis | |
| CN103736011B (en) | Injection care drug of a kind of cholesterol reducing and preparation method thereof | |
| CN101612233B (en) | Chinese medicine preparation for detumescence and analgesia | |
| CN102727755A (en) | Traditional Chinese medicine composition for treating gastric ulcer | |
| CN106138718A (en) | A kind of preparation method treating enteritis Chinese medicine | |
| CN105943597A (en) | Traditional Chinese medicine composition capable of enhancing immunity and preventing and treating radiation diseases | |
| CN105125815A (en) | Traditional Chinese medicine composition for hair restoring and preparation method thereof | |
| CN103830654A (en) | Traditional Chinese medicine for treating infantile zinc deficiency |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20160831 |
|
| WD01 | Invention patent application deemed withdrawn after publication |